Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Change in Intangibles (2019 - 2020)

Summit Therapeutics (SMMT) has disclosed Change in Intangibles for 2 consecutive years, with -$168000.0 as the latest value for Q3 2020.

  • For the quarter ending Q3 2020, Change in Intangibles changed N/A year-over-year to -$168000.0, compared with a TTM value of -$168000.0 through Jun 2021, changed N/A, and an annual FY2019 reading of $136000.0, changed N/A over the prior year.
  • Change in Intangibles was -$168000.0 for Q3 2020 at Summit Therapeutics, down from $4000.0 in the prior quarter.
  • Across five years, Change in Intangibles topped out at $164000.0 in Q1 2020 and bottomed at -$168000.0 in Q3 2020.